Kallikrein-inhibitor therapies
US7153829B2 · kind B2 · utility
31Cited by
24References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 27, 2004 |
| Grant date | Dec 26, 2006 |
| Priority date | — |
| Expiry date | Oct 23, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods are described for preventing or reducing ischemia, e.g., cerebral ischemia, and/or reperfusion injury, e.g., reperfusion injury associated with cerebral ischemia, in a patient.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.